BMO Analysts Say Merck's Fundamentals Don't Justify Its Valuations By: Benzinga via Benzinga July 18, 2016 at 12:02 PM EDT BMO has downgraded Merck & Co., Inc. (NYSE: MRK) shares to Market Perform from Outperform on valuation. "The so called 'TINA' (there is ... Read More >> Related Stocks: Bank of Montreal Bristol-Myers Squibb Eli Lilly Merck & Co